Many Investors Are Still Treating Gilead Sciences Like a Has-Been HIV Stock. 4 Drug Launches This Year Could Prove Them Wrong.

If I Could Tell Every Investor 1 Thing About the Next 12 Months in the Stock Market, It's This

2026/07/12

Trump says Strait of Hormuz remains open after U.S. strikes on Iran

2026/07/12

This is how rich SpaceX workers are after the IPO

2026/07/12

A Smarter Alternative to the Vanguard S&P 500 ETF for Risk-Aware Investors

2026/07/12